Related Experiment Video

Updated: Mar 26, 2026

An Obstructive Chronic Pancreatitis Model Established Through Electrocoagulation
06:28

An Obstructive Chronic Pancreatitis Model Established Through Electrocoagulation

Published on: October 31, 2025

544

CFTR: A New Horizon in the Pathomechanism and Treatment of Pancreatitis

Péter Hegyi1,2,3, Michael Wilschanski4, Shmuel Muallem5

  • 1Institute for Translational Medicine and 1st Department of Medicine, University of Pécs, Pécs, Hungary. hegyi.peter@med.u-szeged.hu.

Reviews of Physiology, Biochemistry and Pharmacology
|February 10, 2016
PubMed

Insights

Cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction is critical in pancreatitis development. Correcting CFTR function offers a promising new therapeutic strategy for pancreatitis.

Area of Science:

  • Cell Biology
  • Gastroenterology
  • Genetics

Background:

  • Cystic fibrosis transmembrane conductance regulator (CFTR) is an ion channel crucial for epithelial fluid transport.
  • CFTR mutations cause cystic fibrosis, but also increase pancreatitis risk in carriers.
  • Pancreatitis-inducing factors inhibit CFTR function, and reduced CFTR is observed in pancreatitis.

Purpose of the Study:

  • To review recent advances in understanding CFTR's role in pancreatitis.
  • To explore novel therapeutic strategies targeting CFTR for pancreatitis treatment.

Main Methods:

  • Literature review of studies on CFTR, pancreatitis, and potential therapies.
  • Analysis of findings linking CFTR dysfunction to pancreatitis pathogenesis.
  • Discussion of emerging treatment possibilities for pancreatitis.

Main Results:

  • CFTR dysfunction is a key factor in pancreatitis development.
  • Environmental insults exacerbate pancreatitis by inhibiting CFTR.
  • Reduced CFTR expression and function are hallmarks of pancreatitis.

Conclusions:

  • Impaired CFTR function is critical for pancreatitis.
  • Targeting CFTR represents a potential specific therapy for pancreatitis.
  • Further research into CFTR modulation may lead to effective pancreatitis treatments.
Keywords:
CFTRCystic fibrosisEpithelial transportPancreasPancreatitis

More Related Videos

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

677
Purification of the Cystic Fibrosis Transmembrane Conductance Regulator Protein Expressed in Saccharomyces cerevisiae15:12

Purification of the Cystic Fibrosis Transmembrane Conductance Regulator Protein Expressed in Saccharomyces cerevisiae

Published on: May 10, 2014

15.1K

Related Concept Videos

Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
871
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
475
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.0K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
616
Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
1.5K
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
1.0K